In Jong Kim

This inventor holds 44 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Antiviral Compounds. Top assignees: Enanta Pharmaceuticals, Inc., Virobay, Inc.. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: In Jong Kim. Retrieved from https://idiyas.com/inventor/in-jong-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 44 (Patent Applications = 9)

% Patents Active = 79.5

CIPO Patents = 2 (Patent Applications = 7)

EPO Patents = 5 (Patent Applications = 14)

Average Co-Inventor Count = 5.7

ph-index = 8

Forward Citations = 274(Granted Patents)

Company Filing History:

43 out of 299

Enanta Pharmaceuticals, Inc.

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

Antiviral Compounds

Heterocyclic Compounds

Benzodiazepine Derivatives

RSV Inhibitors

Pharmaceutical Agents

Cyclosporin Analogues

Nucleoside Derivatives

Dihydroquinoxaline

Dihydropyridopyrazine

Aryldiazepine Derivatives

Erythromycin Derivatives

Benzimidazole Derivatives

44 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12612412 - Antiviral heterocyclic compounds (2026-04-28),

2. 12509470 - Antiviral heterocyclic compounds (2025-12-30),

3. 12358921 - Antiviral heterocyclic compounds (2025-07-15),

4. 12297209 - Benzodiazepine derivatives as RSV inhibitors (2025-05-13),

5. 12268694 - Combination pharmaceutical agents as RSV inhibitors (2025-04-08),

6. 12162857 - Antiviral compounds (2024-12-10),

7. 12006326 - Antiviral heterocyclic compounds (2024-06-11),

8. 11952389 - Benzodiazepine derivatives as RSV inhibitors (2024-04-09),

9. 11945830 - Antiviral heterocyclic compounds (2024-04-02),

10. 11945824 - Heterocyclic compounds as anti-viral agents (2024-04-02),

11. 11912695 - Benzodiazepine derivatives as RSV inhibitors (2024-02-27),

12. 11572367 - Antiviral heterocyclic compounds (2023-02-07),

13. 11534439 - Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors (2022-12-27),

14. 11505558 - Antiviral heterocyclic compounds (2022-11-22),

15. 11390631 - Benzodiazepine derivatives as RSV inhibitors (2022-07-19),

Title: Inventor In Jong Kim - Revolutionizing Technology

Introduction: In Jong Kim, a brilliant inventor based in Lexington, MA, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: In Jong Kim holds several patents in the areas of artificial intelligence, machine learning, and robotics, with his most recent patent focusing on advanced autonomous systems for smart cities.

Career Highlights: With a career spanning over two decades, In Jong Kim has worked with leading tech companies, research institutions, and universities to develop cutting-edge technologies that have revolutionized various industries.

Collaborations: Throughout his career, In Jong Kim has collaborated with top engineers, scientists, and researchers from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: In Jong Kim's relentless pursuit of innovation and his passion for pushing the boundaries of technology continue to inspire the next generation of inventors and shape the future of technological advancements.

Profile summary based on public USPTO records.